Gofen & Glossberg’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Gofen & Glossberg’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,685	Closed	-$365K	–	578
2021 Q1	$365K	Buy	+1,685	New	+$317K	0.01%	378
2020 Q3	–	Sell	-1,685	Closed	-$207K	–	484
2020 Q2	$207K	Buy	+1,685	New	+$191K	0.01%	414
2019 Q4	–	Sell	-2,875	Closed	-$331K	–	490
2019 Q3	$331K	Hold	2,875	–	–	0.01%	345
2019 Q2	$496K	Hold	2,875	–	–	0.02%	291
2019 Q1	$485K	Hold	2,875	–	–	0.02%	283
2018 Q4	$280K	Buy	2,875 +815	+40%	+$107K	0.01%	350
2018 Q3	$356K	Buy	+2,060	New	+$297K	0.01%	337

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Gofen & Glossberg's GWPH Position: Q2 2021 in Review

Gofen & Glossberg sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,685 shares — an estimated $365K sold.

Gofen & Glossberg first reported a position in GWPH in Q3 2018 and held it in 7 quarters. The position peaked at $496K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Gofen & Glossberg reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Gofen & Glossberg sold 1,685 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $365K.
Gofen & Glossberg first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 7 quarters.
Gofen & Glossberg's GW Pharmaceuticals Plc American Depositary Shares position peaked at $496K in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Gofen & Glossberg's 13F filing for Q2 2021, filed 13 Jul 2021.